Form D · Private Equity Fund

Blackstone Life Sciences VI (LUX) SCSp

New York, NY · CIK 0002026410

Offering snapshot reported Apr 2, 2026 · SEC filing

Reported sold: $6.3B
Investors reported: 23
Minimum accepted: $0
First sale: Dec 18, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,615,298,293 → $6,300,000,000
Reported investors15 → 23

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 2, 2026	Amendment	$6,300,000,000	$2,684,701,707vs Dec 9, 2025	23	SEC filing
Dec 9, 2025	Amendment	$3,615,298,293	$322,461,800vs Oct 8, 2025	15	SEC filing
Oct 8, 2025	Amendment	$3,292,836,493	No comparison	15	SEC filing
Dec 17, 2024	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-532387

Total Amount Sold includes the General Partner's commitment as well as sales in parallel funds and sales made under Regulation S.

Source: Form D, filed Apr 2, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BLACKSTONE LIFE SCIENCES VI (LUX) SCSP

Investment adviser: BLACKSTONE LIFE SCIENCES ADVISORS L.L.C.

Gross asset value: $373M
Beneficial owners: 17
ADV minimum commitment: $10M

Reported in Form ADV on Mar 30, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator CACEIS INVESTOR SERVICES BANK S.A. ESCH-SUR-ALZETTE, Luxembourg Investor statements: Yes (provided to all investors) Related to adviser: No

Custodian BANK OF AMERICA, N.A. WILMINGTON, Delaware, United States Related to adviser: No

Custodian CACEIS INVESTOR SERVICES BANK S.A. ESCH-SUR-ALZETTE, Luxembourg Related to adviser: No

Custodian UBS FINANCIAL SERVICES INC. BOSTON, Massachusetts, United States Related to adviser: No

Provider details

Annual audit: No
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

Filing source

Form ADV 2068503 · Mar 30, 2026 · Schedule D 7.B.(1), fund 805-9419227203

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Joseph Baratta	Executive
N/A Blackstone Life Sciences Associates Vi L.P.	Promoter
N/A Blackstone Life Sciences Associates Vi (Lux) S.A R.L.	Promoter
N/A Bxls Vi L.L.C.	Promoter
Julie Constable	Executive
Mathias Favetto	Executive
John G. Finley	Executive
Nicholas Galakatos	Executive
Elsa Gelin	Executive
Ilan Halal	Executive
Tabea Hsi	Executive
Natacha Jamar	Executive
Eric Liaw	Executive
Robert Liptak	Executive
Nentcho Nentchev	Executive
Alicia Novak	Executive
Chris Placca	Executive
Victoria Portnoy	Executive
Omar Rehman	Executive
Christopher Striano	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

345 Park Avenue
New York, NY, 10154